Speer Medical Technologies is a biotechnology company dedicated to the research and development of targeted radionuclide therapies and cancer medications for patients lacking effective and safe cancer treatment options. We utilize innovative proprietary technology and years of oncology research to refine these therapies and drugs to make them safer to non-cancerous cells and more effective in isolating and killing cancer cells.

As part of our ongoing mission to develop better treatments and therapies for cancer patients, Speer Medical Technologies utilizes a high linear energy transfer (LET) radionuclide platform to develop and synthesize new drugs. The cytotoxic radionuclides are attached to tumor specific targeting molecules.

If you have any questions regarding our company or our industry research in the field of oncology, we invite you to Contact Us today.